|Videos|June 15, 2023
Screening Opportunities and Policy Updates in HCV
Author(s)Parvez Mantry, MD, Mamta Jain, MD, MPH
Parvez Mantry, MD, examines the question of why so many patients with HCV do not undergo therapy. He also discusses policy updates aimed at improving screening and expanding access to treatment.
Advertisement
Advertisement
Related to this article
October 2026 hepatology news includes FDA approval of bepirovirsen for hepatitis B, new ACLF criteria, ACG cirrhosis guidance, and MASH trial data.
Advertisement
Advertisement
Trending on HCPLive
1
Oral STAT6 Degrader KT-621 Reduces EASI by 62.6% in Atopic Dermatitis
2
Q&A: Tulisokibart Results and TL1A Inhibition in HS, With Alexa Kimball, MD, MPH
3
Risankizumab Shows Higher 3-Year Drug Survival in Psoriasis With PsA
4
Q&A: Asthma Remission from Year 1 To Year 2 With Depemokimab
5